qXR-CTR vs VX1
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is automated, rapid assessment of heart size and potential heart failure risk from standard chest X-ray images. This tool is ideal for high-volume screening environments or for radiologists and cardiologists seeking an AI-powered aid to quickly identify patients who may require further cardiac evaluation based on their cardiothoracic ratio.
View qXR-CTR →Choose VX1 if…
Choose VX1 if you are a cardiac electrophysiologist performing atrial fibrillation or atrial tachycardia ablation procedures and require real-time AI guidance. This software is specifically designed to assist in identifying dispersed electrograms during these complex interventions, aiming to enhance procedural efficacy and reduce variability.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | VX1 |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRTool A (qXR-CTR) automates the measurement of the cardiothoracic ratio from chest X-ray images, integrating into existing radiology workflows with minimal user interaction. Tool B (VX1) provides real-time assistance during complex cardiac ablation procedures, requiring active engagement from highly specialized electrophysiologists. While both are valuable, Tool A's automated, less interactive nature suggests a simpler overall user experience for a broader range of clinical users.
Clinical Value
VX1Tool B (VX1) offers real-time AI-guided assistance during complex atrial fibrillation and atrial tachycardia ablation procedures, aiming to reduce inter-operator variability and standardize outcomes. This directly impacts the efficacy and safety of an interventional procedure. Tool A (qXR-CTR) provides diagnostic aid for assessing heart size and potential heart failure risk from chest X-rays, which is valuable but less directly impactful on an active, high-stakes treatment.
Pricing & Value
TieBoth tools explicitly state 'contact for pricing' and do not publicly disclose their pricing details. Without any publicly available information on cost or specific value propositions beyond their technical descriptions, it is impossible to conduct a head-to-head comparison of their pricing and overall value. Therefore, a tie is appropriate for this dimension.
Enterprise Readiness
qXR-CTRTool A (qXR-CTR) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, along with flexible deployment options including cloud, on-premise, and hybrid. Tool B (VX1) does not explicitly state BAA or HIPAA compliance in the provided facts, and its deployment is more specialized, integrating with existing EP lab systems. Tool A demonstrates greater transparency and flexibility in enterprise-level deployment and compliance.
Innovation
VX1Tool B (VX1) represents a highly innovative application of AI by providing real-time, AI-guided identification of dispersed electrograms during complex cardiac ablation procedures, directly assisting electrophysiologists in a live interventional setting. Tool A (qXR-CTR) automates the measurement of the cardiothoracic ratio from static chest X-ray images, which, while useful, is a less complex and interactive application of AI compared to real-time procedural guidance.
Support & Docs
TieBoth Qure.ai (Tool A) and Volta Medical (Tool B) generally mention offering support and training on their respective websites. However, specific details regarding the depth of documentation, public access to manuals, response times, or tiered support structures are not sufficiently detailed or differentiated in the provided facts or web searches to determine a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | VX1 |
|---|---|---|
| Name | qXR-CTR | VX1 |
| Company | Qure.ai Technologies | Volta Medical |
| Primary Function | Automates measurement of cardiothoracic ratio (CTR) from chest X-ray images to assess heart size and potential heart failure risk. | Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Target Specialties | Cardiology, Radiology | Cardiology |
| Key Features | Not specified | AI-guided real-time identification of dispersed electrograms (EGMs); Assists cardiologists during AFib and atrial tachycardia ablation procedures; Analyzes 3D anatomical and electrical maps of human atria; Compatible with most EP recording, 3D navigation systems, and mapping catheters; Designed to reduce inter-operator variability and standardize outcomes; Provides cycle length estimation from electrograms; Booster mode for increased sensitivity during AT or slow AF. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Surgical AI |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and VX1.